Replies to post #587804 on NorthWest Biotherapeutics Inc (NWBO)

[scotty3371]

Exactly. I look at lp as the destroyer of dcvax!!!

.50 a share is a reflection of Ms powers effectiveness as ceo.

It's a train wreck.

[dstock07734]

What if big pharma treat you like a beggar? What if big pharma bought NWBO technology and shelf it?
After Merck bought Keytruda, for the first couple of years, the program was almost dead. It was only after BMY reported great results on opidivo that Merck started investing heavily on keytruda.

[Poor Man -]

I agree. From a patient perspective, the quicker this treatment is in the control of a BP the better.

If you care so much for the patients, why wouldn’t you want the management to pass the baton on to big pharma that can scale this very quickly rather than the snails pace at which this team is moving.

[Horseb4CarT]

The point I was making is it works and it means people living. To me that means it will translate to a higher share price.

Yes it’s taking a long time, but it’s a breakthrough and nwbo has had to dodge bombs all along the way.

I can use the return on investment yesterday, however I’m convinced the return, although long In coming will be the best return I’ll have ever made.

I’ve had a few ten baggers, even a 30 bagger, but not yet a 50+ bagger, which I think nwbo has the potential to be.

[dennisdave]

I have very little doubt they will pass the baton after approval likely after MHRA but most probably after FDA approval.

[vator]

Because we already spent the bulk of money by increasing the authorized share count to 1.7 Billion shares in treasury. Give it to MRK and you triple your money in a few years. If you actually control the product you can get much more and not just be part of a large portfolio of products. So if MRK wants to spend a large enough sum I would agree because that would compensate me. Right now even MRK spending $10/share for a product to be used in all solid operable and inoperable tumors would be the shaft. For me anyway. Others think differently.